![Mike I. Sherman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mike I. Sherman
Director/Miembro de la Junta en Accelerated Orthopedic Technologies, Inc. .
Perfil
Mike I.
Sherman is the founder of VaxInnate Corp.
(2002), Iconic Therapeutics, Inc. (2003), and Affomix Corp.
(2008), where he held various titles.
He is also the founder of Molecular Staging, Inc., PharmaGenics, Inc., Prostagen, Inc., Protometrix, Inc. Dr. Sherman's current job is as a Director at Accelerated Orthopedic Technologies, Inc. Dr. Sherman's former jobs include being a Principal at Hoffmann-La Roche, Inc. and a Partner at Elm Street Advisors LLC.
Dr. Sherman earned a doctorate degree from The State University of New York.
Cargos activos de Mike I. Sherman
Empresas | Cargo | Inicio |
---|---|---|
Accelerated Orthopedic Technologies, Inc.
![]() Accelerated Orthopedic Technologies, Inc. Medical DistributorsDistribution Services Accelerated Orthopedic Technologies, Inc. develops proprietary tools for obtaining, shaping, and implanting cartilage grafts. The firm commercializes an innovative approach to repairing cartilage lesions of the ankle and knee with allograft material or autografts using joints in the foot. The company was founded by Thomas E. Wood on February 18, 2009 and is headquartered in Guilford, CT. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mike I. Sherman.
Empresas | Cargo | Fin |
---|---|---|
Protometrix, Inc.
![]() Protometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Protometrix, Inc. develops proteomics technologies. The company is headquartered in Carlsbad, CA. | Fundador | - |
VaxInnate Corp.
![]() VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Fundador | - |
Prostagen, Inc.
![]() Prostagen, Inc. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Prostagen, Inc. develops treatments and diagnostics for prostate cancer. The company is based in Allendale, NJ. The company was founded by Mike I. Sherman. Prostagen was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on June 16, 1999 for $2.60 million. | Fundador | - |
Molecular Staging, Inc.
![]() Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Fundador | - |
PharmaGenics, Inc.
![]() PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Fundador | - |
Formación de Mike I. Sherman.
The State University of New York | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 10 |
---|---|
Iconic Therapeutics, Inc.
![]() Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Affomix Corp.
![]() Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | Health Technology |
Accelerated Orthopedic Technologies, Inc.
![]() Accelerated Orthopedic Technologies, Inc. Medical DistributorsDistribution Services Accelerated Orthopedic Technologies, Inc. develops proprietary tools for obtaining, shaping, and implanting cartilage grafts. The firm commercializes an innovative approach to repairing cartilage lesions of the ankle and knee with allograft material or autografts using joints in the foot. The company was founded by Thomas E. Wood on February 18, 2009 and is headquartered in Guilford, CT. | Distribution Services |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Molecular Staging, Inc.
![]() Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Health Technology |
PharmaGenics, Inc.
![]() PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
Prostagen, Inc.
![]() Prostagen, Inc. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Prostagen, Inc. develops treatments and diagnostics for prostate cancer. The company is based in Allendale, NJ. The company was founded by Mike I. Sherman. Prostagen was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on June 16, 1999 for $2.60 million. | Health Technology |
Protometrix, Inc.
![]() Protometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Protometrix, Inc. develops proteomics technologies. The company is headquartered in Carlsbad, CA. | Commercial Services |
VaxInnate Corp.
![]() VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Elm Street Advisors LLC
![]() Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Finance |
- Bolsa de valores
- Insiders
- Mike I. Sherman